MICHAEL W ROGERS Insider Trading $AKBA Akebia Therapeutics, Inc.
Get free email notifications about insider trading for MICHAEL W ROGERS.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of MICHAEL W ROGERS. MICHAEL W ROGERS is Executive Vice President in Endo Pharmaceuticals Solutions Inc. ($IDEV) and Director in KERYX BIOPHARMACEUTICALS INC ($KERX) and Chief Financial Officer in ACORDA THERAPEUTICS INC ($ACOR) and in EyePoint Pharmaceuticals, Inc. ($EYPT) and Director in pSivida Corp. ($PSDV) and Chief Financial Officer in Aerpio Pharmaceuticals, Inc. ($ZETAII) and Director in Aravive, Inc. ($ARAV) and in Akebia Therapeutics, Inc. ($AKBA) and Director in Akebia Therapeutics, Inc. ($AKBA).
MICHAEL W ROGERS in Akebia Therapeutics, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of MICHAEL W ROGERS:
Holdings: 38,629 shares
Current Value: $381,655
Latest Transaction: Jun 09 2020
$AKBA Market Capitalization: $177.33M
$AKBA Previous Close: $9.88
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of MICHAEL W ROGERS in Akebia Therapeutics, Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ACOR, ARPO, AKBA, ARAV, IDEV, EYPT, KERX
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 09 2020 | AKBA | Akebia Therapeutic ... | ROGERS MICHAEL W | Option Exercise | A | 11.96 | 20,100 | 240,396 | 20,100 | ||
| Jun 09 2020 | AKBA | Akebia Therapeutic ... | ROGERS MICHAEL W | Grant | A | 0.00 | 13,700 | 0 | 38,629 | 24.9 K to 38.6 K (+54.96 %) | |
| Jun 10 2019 | AKBA | Akebia Therapeutic ... | ROGERS MICHAEL W | Option Exercise | A | 4.23 | 20,100 | 85,023 | 20,100 | ||
| Jun 10 2019 | AKBA | Akebia Therapeutic ... | ROGERS MICHAEL W | Grant | A | 0.00 | 13,700 | 0 | 24,929 | 11.2 K to 24.9 K (+122.01 %) | |
| Dec 13 2018 | AKBA | Akebia Therapeutic ... | ROGERS MICHAEL W | Director | Option Exercise | A | 8.94 | 25,000 | 223,500 | 25,000 | |
| Dec 13 2018 | AKBA | Akebia Therapeutic ... | ROGERS MICHAEL W | Director | Option Exercise | A | 10.05 | 11,229 | 112,851 | 11,229 | |
| Dec 13 2018 | AKBA | Akebia Therapeutic ... | ROGERS MICHAEL W | Director | Option Exercise | A | 17.53 | 11,229 | 196,844 | 11,229 | |
| Dec 13 2018 | AKBA | Akebia Therapeutic ... | ROGERS MICHAEL W | Director | Option Exercise | A | 15.26 | 11,229 | 171,355 | 11,229 | |
| Dec 13 2018 | AKBA | Akebia Therapeutic ... | ROGERS MICHAEL W | Director | Option Exercise | A | 12.48 | 18,716 | 233,576 | 18,716 | |
| Dec 13 2018 | AKBA | Akebia Therapeutic ... | ROGERS MICHAEL W | Director | Grant | A | 0.00 | 11,229 | 0 | 11,229 | 0 to 11.2 K |
Page: 1